Logo

Paired Ends: Jan 20, 2009

Jan 21, 2009
Premium

Kevin Ulmer joined Complete Genomics last month as a full-time consulting scientist. Previously, he was CSO of Genome Corp., a Rhode Island-based startup that he co-founded. In 2004, he consulted full-time for Helicos BioSciences. Ulmer also founded Seq, a 1987-startup that pursued single-molecule sequencing and was later acquired by Amersham.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.